Literature DB >> 6330872

Prolonged influence of a meal on the effect of ranitidine.

K Frislid, A Berstad.   

Abstract

Ten healthy volunteers received 150 mg ranitidine or placebo. Eight hours after drug administration they were served a standard meal or continued fasting. Four hours later the gastric acid and pepsin secretion and gastrin and ranitidine levels in blood were recorded for a further 2 h. At the time when secretion was measured, the meal neither stimulated acid or pepsin secretion nor altered the circulating plasma levels of ranitidine or gastrin. In spite of that, the meal significantly reduced the acid-inhibitory effect of ranitidine from 63% to 39% (p less than 0.01). Pepsin secretion was not affected by the meal or the administration of ranitidine. The results indicate that a meal may decrease the acid-inhibitory effect of the H2-receptor antagonist longer than it stimulates acid secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330872

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.

Authors:  C H Wilder-Smith; F Halter; W Häcki; H S Merki
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

Review 2.  Pharmacologic management of gastroesophageal reflux disease.

Authors:  Amarnath Ramakrishnan; Philip O Katz
Journal:  Curr Gastroenterol Rep       Date:  2002-06

Review 3.  Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.

Authors:  J G Hatlebakk; A Berstad
Journal:  Clin Pharmacokinet       Date:  1996-11       Impact factor: 6.447

Review 4.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Pharmacologic Management of Gastroesophageal Reflux Disease.

Authors:  Amarnath Ramakrishnan; Philip O. Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2002-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.